News From RSCNJ
New Advances in the art of creating a baby
Nearly one in six couples in the U.S. struggles with some degree of infertility. In these cases, it is crucial to consult with a physician who is on the cutting edge of this fast-paced field. At the Reproductive Science Center of New Jersey, we offer a wide range of fertility services, from evaluation, to the most advanced reproductive procedures including egg donation. But what really sets us apart is our experience and expertise in newer, cutting edge procedures.
In the area of fertility, we are able to evaluate the genetic makeup of embryos through a procedure called PGD (pre-implementation genetic diagnosis), which is used to test the genetic makeup of an embryo for possible disorders before placing it in the uterus. The Reproductive Science Center of New Jersey center recently had the first pregnancy in Monmouth and Ocean counties utilizing CGH (comparative genomic hybridization), the latest advance in PGD.
Another area in which great strides have been made in the field of Reproductive Medicine is in fertility preservation. For women with cancer or other diseases in which treatment may harm their future fertility, there are now more options than ever for protecting their eggs and ovaries. We are now able to cryopreserve, or freeze, eggs and embryos, and some women are even opting to preserve ovarian tissue that contains eggs for possible future transplantation as well.
Robotic surgery is also now being used to treat a number of gynecological problems and has greatly improved the outcome and shortened the recovery time. All of the surgeons at the Reproductive Science Center of New Jersey are trained in robotic surgery, and Dr. Ziegler and Dr. Bromer recently performed the first robotic assisted tubal reversal surgeries in Monmouth and Ocean Counties.
Jason G. Bromer M.D.,F.A.C.O.G. Reproductive Science Center of New Jersey
Study of chemical found in plastics and fetal developement
Bisphenol A (BPA), a chemical compound commonly found in plastics, may have long-term effects on fetal development, according to an article published by Yale School of Medicine researchers last month in the Journal of the Federation of American Societies for Experimental Biology. The results of the study come weeks after the Food and Drug Administration announced that exposure to BPA was of "some concern" to infants and children.
Bromer, who was a fellow at Yale during the study, said researchers now need to determine the levels of BPA exposure that are significant enough to impact fetal development.
Click here to read full article about BPA study.
New Doctor Joins RSC-New Jersey-November, 2009
Dr. Bromer is a specialist in Reproductive Endocrinology and Infertility, and the newest associate of the Reproductive Science Center of New Jersey. He holds teaching positions at both training institutions in Monmouth County; Monmouth Medical Center and Jersey Shore University Medical Center (an Affiliate of the Robert Wood Johnson Medical Center), and he enjoys working with medical students and residents training in Obstetrics and Gynecology.
Dr. Bromer also works closely with Dr. Ziegler in conjunction with these teaching centers to organize continuing medical education programs available to all medical professionals in the community. He is a member of the New Jersey Medical Society, the American Society of Reproductive Medicine, the Society for Reproductive Endocrinology and Infertility, and the International Society for Fertility Preservation. He is a fellow of the American College of Obstetricians and Gynecologists, and is a Diplomat of the American Board of Obstetrics and Gynecology.
Dr. Bromer’s aim is to provide current, high quality medical treatment to his patients in a sensitive, caring, and compassionate environment.
Click here to read full bio.